核苷酸类似物药物治疗乙型肝炎肝硬化的临床实践
聂青和
【期刊名称】《中国实用内科杂志》 【年(卷),期】2014(034)006
【摘要】Researchers within China and worldwide have come to a consensus on antiviral treatment of iLiver cirrhosis with hepatitis B,which has been written in the domestic and foreign relevant guidelines.Clinicians have been paying attention to the antiviral treatment of liver cirrhosis,how to achieve the goal of treatment,and how to treat drug-induced side effects,etc.This paper mainly discusses the diagnosis and staging of liver cirrhosis,importance and goal of antiviral treatment,course of treatment,and clinical characteristics of five nucleoside analogues (acid),emphasizes that antiviral treatment can only slow progression in liver disease,but cannot change the results of end end-stage liver cirrhosis.The author considers that timely antiviral treatment is essential and anti-fibrosis treatment is necessary for liver cirrhosis
with
hepatitis
B
patients
in
clinical
practice.Meanwhile,compliance should be introduced at the same time to patients,because compliance education is the key to achieve treatment goals.%目前临床医生一直在关注乙肝肝硬化抗病毒治疗的疗程以及如何达到治疗目标、药物副反应如何认识等.该文重点论述了肝硬化诊断与分期,患者抗病毒治疗的重要性及治疗目标、疗程.5个核苷(酸)类似物的临床特点,
核苷酸类似物药物治疗乙型肝炎肝硬化的临床实践
